Week in Review: April 21–25

Evolution of Y chromosome; delivering gene with “bionic ears”; diversity of an important cyanobacterium; charting genome-sequencing progress; blockbuster pharma deals

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, ARCHAEOGENETICSTwo independent teams have uncovered evidence to suggest that a core set of Y chromosome genes are critical not just for sex determination, but also for transcription, translation, and other regulatory functions throughout the genome. Their work was published in Nature this week (April 23).

In the face of lingering theories that the Y chromosome is on its way to extinction, these papers provide “a tremendous rational for why these genes have been retained,” said geneticist Carlos Bustamante of Stanford Medical School, who was not involved in the work.

UNIVERSITY OF NEW SOUTH WALESResearchers have long sought to deliver brain-derived neurotrophic factor (BDNF) to the cochlea to stimulate neuronal growth and treat hearing loss. Now, a team from the University of New South Wales has come up with a new solution—loading up cochlear implants with BDNF before surgery. Once implanted, the devices deliver the gene locally via brief electric bursts. The team’s work was published in Science Translational Medicine this week (April 23).

“Using BDNF to grow spiral ganglion cell neurites toward electrodes is an old idea (yet still an important one), but the use of the electrode array to focus targeted gene therapy as described is highly innovative,” Jay Rubinstein from the University of Washington, who was not involved in the work, told The Scientist in an e-mail.

MIT, CARLY SANKERExamining the high-light–adapted strain of the cyanobacterium Prochlorococcus, scientists from MIT and their colleagues unearthed high diversity within individual genomes.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies